KAT2A Antikörper
-
- Target Alle KAT2A Antikörper anzeigen
- KAT2A (K(lysine) Acetyltransferase 2A (KAT2A))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser KAT2A Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), Immunofluorescence (IF)
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein of human KAT2A (NP_066564.2).
- Isotyp
- IgG
- Top Product
- Discover our top product KAT2A Primärantikörper
-
-
- Applikationshinweise
- IHC 1:50-1:200 IF 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- KAT2A (K(lysine) Acetyltransferase 2A (KAT2A))
- Andere Bezeichnung
- KAT2A (KAT2A Produkte)
- Hintergrund
- KAT2A (Lysine Acetyltransferase 2A) is a Protein Coding gene. Diseases associated with KAT2A include Spinocerebellar Ataxia 7 and Chromosome 16P13.3 Deletion Syndrome, Proximal. Among its related pathways are Chromatin organization and E2F transcription factor network. Gene Ontology (GO) annotations related to this gene include chromatin binding and transcription coactivator activity. An important paralog of this gene is KAT2B.
- Molekulargewicht
-
Observed_MW: 94kDa
Calculated_MW: 94kDa
- Gen-ID
- 2648
- UniProt
- Q92830
- Pathways
- Chromatin Binding, Tube Formation
-